- C.E.R.A. Administered at Extended Dosing Intervals Corrects Anemia and Maintains Stable Hemoglobin Levels in Patients with Chronic Kidney Disease (CKD) not on Dialysis
Provenzano, R., Schmidt, R., Dalton, C., Beswick, R., Nassar, G., C.E.R.A.
Administered at Extended Dosing Intervals Corrects Anemia and Maintains Stable
Hemoglobin Levels in Patients with Chronic Kidney Disease (CKD) not on
Dialysis. ESRD Forum Meeting, Baltimore, MD,
2007.
- Comparison of Quality-of-Hypertension-Care Indicators for Groups Treated by Physician Versus Groups Treated by Physician-Nurse Team
[
View this article on MedScape.com via Google search]
Scisney-Matlock, M., Makos, G., Saunders, T., Jackson, F., Steigerwalt, S.,
Comparison of Quality-of-Hypertension-Care Indicators for Groups Treated by
Physician Versus Groups Treated by Physician-Nurse Team, Journal of the American Academy of Nurse
Practitioners, Vol. 16, No. 1, January, 2004.
FROM THE ARTICLE: Epidemiologic studies show that hypertension (HTN), which can lead to
arteriosclerosis, cerebrovascular disease, coronary disease, and
end-stage renal disease, places a disproportionate burden of mortality
and morbidity on African Americans, with African American women in
particular having the highest incidence.
- Arterial Anastomosis Disruption in Two Kidney Recipients of Contaminated Grafts from a Donor With Gorham's Syndrome
Saidi, R.F., Fasola, C., El-Ghoroury, M., Oh, H., Arterial Anastomosis Disruption in Two Kidney
Recipients of Contaminated Grafts from a Donor with Gorham’s Syndrome, Transplant Proceedings, 36(5): 1392-4, June
2004.
- Use of Aldosterone Antagonists (AA) Are Associated with Achieved Blood Pressure (BP) Control in Chronic Kidney Disease (CKD)
Topf, J., Steigerwalt, S., Provenzano, R., Use of Aldosterone Antagonists
(AA) Are Associated with Achieved Blood Pressure (BP) Control in Chronic Kidney
Disease (CKD). American Society of Nephrology 39th Annual
Meeting, San Diego,
CA, 2006.
- CKD (Chronic Kidney Disease) Clinics Improve Anemia, Lipids and Arrest the Decline of GFR
Topf, J., Provenzano, R., Abud, G., CKD (Chronic Kidney Disease) Clinics
Improve Anemia, Lipids and Arrest the Decline of GFR, American Society of
Nephrology 39th Annual Meeting, San Diego, CA, 2006.
- A Double-Blind, Placebo-Controlled, Randomized Phase III Study of the Safety of Ferumoxytol – A New Intravenous Iron Replacement Therapy
Singh, A., Besarab, A. Bolton, W., Pereira, B, Provenzano, R., Rao, M.,
Spinowitz, B., A Double-Blind, Placebo-Controlled, Randomized Phase III Study
of the Safety of Ferumoxytol – A New Intravenous Iron Replacement Therapy,
American Society of Nephrology 39th Annual Meeting, San Diego, CA,
2006.
- Parenteral Iron Therapy with Ferumoxytol in Hemodialysis: A Phase III Study
Besarab, A., Bolton, W., Pereira, B., Provenzano, R., Singh, A., Rao, and
Spinowitz, B. Parenteral Iron Therapy with Ferumoxytol in Hemodialysis: A
Phase III Study, American Society of Nephrology 39th Annual
Meeting, San Diego, CA, 2006.
- Blood Pressure (BP) Control by Race, Gender and Chronic Kidney Disease (CKD) Stage in a CKD Clinic
Topf, J., Steigerwalt, S., Blood Pressure (BP) Control by Race, Gender and
Chronic Kidney Disease (CKD) Stage in a CKD Clinic. National Kidney
Foundation Spring Clinical Meeting, Chicago, IL,
2006.
- Ferumoxytol as Intravenous Iron Replacement Therapy in Chronic Kidney Disease (CKD) Patients Not on Dialysis – Evaluation of Safety and Efficacy in Two Phase III Studies
Spinowitz, B., Besarab, A., Bolton, W., Pereira, B., Provenzano, R., Rao, M.,
Singh, A. Ferumoxytol as Intravenous Iron Replacement Therapy in Chronic
Kidney Disease (CKD) Patients Not on Dialysis – Evaluation of Safety and
Efficacy in Two Phase III Studies, American Society of Nephrology
39th Annual Meeting, San Diego, CA, 2006.
- Blood Pressure (BP) Control by Race, Gender and Chronic Kidney Disease (CKD) Stage in a CKD Clinic
Topf, J., Steigerwalt, S., Provenzano, R., Blood Pressure (BP) Control by
Race, Gender and Chronic Kidney Disease (CKD) Stage in a CKD Clinic,
American Society of Hypertension 21st Annual Scientific Meeting, New
York, NY, 2006.
- Comparison Study Between the Nocturnal Hemodialysis and the Traditional Hemodialysis
Jabri, Muhammad, Topf, Joel,
Comparison Study Between the Nocturnal Hemodialysis and the Traditional
Hemodialysis, American College of Physicians Regional Meeting, Traverse
City, MI, 2006.
- Subcutaneous (SC) CERA (Continuous Erythropoietin Receptor Activator) Administered Once Every 2 Weeks Effectively Corrects Anemia in Patients with Chronic Kidney Disease (CKD) on Dialysis and Not on Dialysis
Provenzano, R., Dougherty, F., Subcutaneous (SC) CERA (Continuous
Erythropoietin Receptor Activator) Administered Once Every 2 Weeks Effectively
Corrects Anemia in Patients with Chronic Kidney Disease (CKD) on Dialysis and
Not on Dialysis. National Kidney Foundation Clinical Meetings, Chicago, IL, 2006.
- Minimal Change Disease with Incidental Mesangial IgA Deposits Preceding Hodgkin’s Lymphoma.
Jefic, D., Topf, J., Minimal Change Disease with Incidental Mesangial IgA
Deposits Preceding Hodgkin’s Lymphoma. National Kidney Foundation Clinical
Meetings, Chicago,
IL, 2006.
- Preference for Information and Blood Pressure Control Status Influence Blood Pressure Reductions in Women,
Steigerwalt, S., Makos, G., Scisney-Matlock, M., Preference for Information
and Blood Pressure Control Status Influence Blood Pressure Reductions in
Women, American Society of Hypertension 21st Annual Scientific
Meeting, New York, NY, 2006.
- Aldosterone Antagonists (AA) Are Associated with Achieved Target Blood Pressure in Chronic Kidney Disease (CKD)
Topf, J., Steigerwalt, S., Aldosterone Antagonists (AA) Are Associated with
Achieved Target Blood Pressure in Chronic Kidney Disease (CKD). National
Kidney Foundation Spring Clinical Meeting, Chicago, IL,
2006.
- Cyanide Toxicity from Nitroprusside in a Patient with Chronic Kidney Disease
- The Impact of Avoiding Both Steroids and Calcineurin Inhibitors on Polyomavirus-Associated Nephropathy in Kidney Transplantation
Brar, N., Butcher, D., El-Ghoroury, M., Provenzano, R., The Impact of
Avoiding Both Steroids and Calcineurin Inhibitors on Polyomavirus-Associated
Nephropathy in Kidney Transplantation, National Kidney Foundation Spring
Clinical Meeting, Chicago,
IL, 2006.
- Lactic Acidosis Cannot Be Used to Explain an Osmolal Gap in Patients with Potential Ethylene Glycol Toxicity: A Case Report and Review of the Literature
Topf, J., Jayakar, S., Lactic Acidosis Cannot Be Used to Explain an Osmolal
Gap in Patients with Potential Ethylene Glycol Toxicity: A Case Report and
Review of the Literature. National Kidney Foundation Spring Clinical
Meeting, Chicago, IL, 2006.
- C-Reactive Protein Levels Do Not Predict Acute Rejection in Kidney Transplant Recipients
Butcher, D., El-Ghoroury, M., Bellovich, K., Provenzano, R., C-Reactive
Protein Levels Do Not Predict Acute Rejection in Kidney Transplant
Recipients, National Kidney Foundation Spring Clinical Meeting, Chicago, IL,
2006.
- Basiliximab Versus Thymoglobulin Induction for Steroid-Free Maintenance Immunosuppression in Live Kidney Transplant Recipients
Butcher, D., Aryan, M., El-Ghoroury, M., Provenzano, R., Granger, D., Oh, H.,
Basiliximab Versus Thymoglobulin Induction for Steroid-Free Maintenance
Immunosuppression in Live Kidney Transplant Recipients. American Society of
Nephrology, Philadelphia,
PA, 2005.
- Pretransplant C-Reactive Protein Levels Do Not Predict Renal Function or Graft Survival at One Year
Butcher, D., Kassar, A., Bellovich, K., El-Ghoroury, M., Provenzano, R.,
Pretransplant C-Reactive Protein Levels Do Not Predict Renal Function or
Graft Survival at One Year. American Society of Nephrology, Philadelphia, PA, 2005.
- Antiphospholipid Antibodies in Chronic Kidney Disease
Nagrecha, M., Topf, J. Antiphospholipid Antibodies in Chronic Kidney
Disease. American Society of Nephrology, Philadelphia, PA, 2005.
- Impact of Avoiding Loading Dose of Sirolimus on Wound Complication After Kidney Transplant. A Single Center Experience
Ayran, M., Jabri, M., El-Ghoroury, M., Oh, H., Provenzano, R., Impact of
Avoiding Loading Dose of Sirolimus on Wound Complication After Kidney
Transplant. A Single Center Experience. American
Transplant Congress, Seattle, WA ,
2005.
- Baxiliximab Versus Thymoglobulin Induction for Steroid-Free Maintenance Immunosuppression in Live Kidney Transplant Recipients
Butcher, D., El-Ghoroury, M., Provenzano, R., Granger, D., Oh, H.,
Baxiliximab Versus Thymoglobulin Induction for Steroid-Free Maintenance
Immunosuppression in Live Kidney Transplant Recipients, Transplant
Immunosuppression 2005: Improving Recipient Outcome, University of Minnesota, 2005. (Oral Presentation)
- Prevalence and Treatment of Anemia in Patients with Hypertension and Chronic Kidney Disease
McClellan, W., Provenzano, R., Prevalence and Treatment of Anemia in Patients
with Hypertension and Chronic Kidney Disease. Heart Failure Society of
America, 9th Annual Scientific Meeting, Boca
Raton, FL, 2005.
